 Jason Aoto
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 11 | 2024 | 592 | 3.080 |
Why?
| | Hippocampus | 17 | 2026 | 965 | 3.000 |
Why?
| | Synapses | 17 | 2026 | 439 | 2.730 |
Why?
| | Receptors, AMPA | 10 | 2025 | 147 | 1.650 |
Why?
| | Synaptic Transmission | 11 | 2024 | 290 | 1.630 |
Why?
| | Neurons | 10 | 2024 | 1640 | 1.450 |
Why?
| | Cell Adhesion Molecules, Neuronal | 4 | 2024 | 42 | 1.270 |
Why?
| | Interneurons | 3 | 2021 | 128 | 0.920 |
Why?
| | Sex Characteristics | 3 | 2026 | 790 | 0.900 |
Why?
| | Nerve Net | 2 | 2026 | 285 | 0.760 |
Why?
| | Nucleus Accumbens | 1 | 2023 | 132 | 0.690 |
Why?
| | GABAergic Neurons | 1 | 2021 | 35 | 0.690 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 86 | 0.660 |
Why?
| | Neural Inhibition | 1 | 2021 | 178 | 0.640 |
Why?
| | Cytological Techniques | 1 | 2020 | 28 | 0.630 |
Why?
| | Synaptic Vesicles | 2 | 2019 | 40 | 0.630 |
Why?
| | Calcium | 3 | 2023 | 1183 | 0.610 |
Why?
| | Protein Aggregates | 1 | 2020 | 86 | 0.600 |
Why?
| | Cell Communication | 1 | 2020 | 324 | 0.550 |
Why?
| | Anxiety | 1 | 2025 | 1109 | 0.530 |
Why?
| | Stress, Psychological | 1 | 2025 | 1152 | 0.490 |
Why?
| | Neural Cell Adhesion Molecules | 4 | 2023 | 38 | 0.490 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2023 | 192 | 0.480 |
Why?
| | Mice | 17 | 2025 | 18339 | 0.470 |
Why?
| | Animals | 24 | 2026 | 38058 | 0.470 |
Why?
| | Alternative Splicing | 2 | 2019 | 247 | 0.460 |
Why?
| | Olfactory Bulb | 2 | 2015 | 97 | 0.430 |
Why?
| | Long-Term Potentiation | 4 | 2025 | 200 | 0.430 |
Why?
| | Calcium-Binding Proteins | 5 | 2023 | 219 | 0.380 |
Why?
| | Neuronal Plasticity | 4 | 2024 | 309 | 0.380 |
Why?
| | HEK293 Cells | 5 | 2024 | 744 | 0.360 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2024 | 117 | 0.350 |
Why?
| | Tretinoin | 2 | 2008 | 124 | 0.330 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5992 | 0.330 |
Why?
| | Mutation, Missense | 2 | 2024 | 340 | 0.320 |
Why?
| | Cells, Cultured | 8 | 2024 | 4154 | 0.310 |
Why?
| | Ligands | 2 | 2023 | 673 | 0.310 |
Why?
| | Glutamic Acid | 3 | 2023 | 251 | 0.300 |
Why?
| | Endocytosis | 2 | 2025 | 168 | 0.300 |
Why?
| | Pyramidal Cells | 1 | 2008 | 79 | 0.270 |
Why?
| | Ephrin-B3 | 1 | 2007 | 1 | 0.270 |
Why?
| | Ephrins | 1 | 2006 | 8 | 0.250 |
Why?
| | Behavior, Animal | 3 | 2025 | 519 | 0.250 |
Why?
| | Rats | 5 | 2024 | 5597 | 0.240 |
Why?
| | Epilepsy | 2 | 2021 | 376 | 0.230 |
Why?
| | Parvalbumins | 2 | 2024 | 26 | 0.230 |
Why?
| | Mice, Knockout | 4 | 2021 | 3121 | 0.230 |
Why?
| | Receptors, Adrenergic | 1 | 2025 | 20 | 0.230 |
Why?
| | Restraint, Physical | 1 | 2025 | 75 | 0.230 |
Why?
| | Septal Nuclei | 1 | 2025 | 23 | 0.220 |
Why?
| | Protein Transport | 3 | 2024 | 441 | 0.220 |
Why?
| | Acyltransferases | 1 | 2025 | 78 | 0.210 |
Why?
| | Globus Pallidus | 1 | 2024 | 25 | 0.210 |
Why?
| | Corticosterone | 1 | 2025 | 244 | 0.210 |
Why?
| | Male | 10 | 2026 | 72315 | 0.200 |
Why?
| | Ventral Tegmental Area | 1 | 2024 | 60 | 0.200 |
Why?
| | Memory Disorders | 1 | 2025 | 193 | 0.200 |
Why?
| | Structure-Activity Relationship | 1 | 2024 | 570 | 0.200 |
Why?
| | Receptors, Dopamine | 1 | 2023 | 19 | 0.190 |
Why?
| | Signal Transduction | 6 | 2016 | 5226 | 0.190 |
Why?
| | Cocaine | 1 | 2024 | 160 | 0.190 |
Why?
| | Receptors, GABA-A | 1 | 2023 | 138 | 0.180 |
Why?
| | Endoplasmic Reticulum | 1 | 2024 | 266 | 0.180 |
Why?
| | Female | 8 | 2026 | 78271 | 0.180 |
Why?
| | Optogenetics | 2 | 2023 | 109 | 0.180 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2021 | 7 | 0.180 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2021 | 48 | 0.170 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 2 | 2023 | 226 | 0.170 |
Why?
| | Protein Binding | 2 | 2024 | 2273 | 0.170 |
Why?
| | Autistic Disorder | 2 | 2015 | 211 | 0.170 |
Why?
| | Parasympathetic Nervous System | 1 | 2021 | 26 | 0.170 |
Why?
| | Motor Disorders | 1 | 2021 | 17 | 0.170 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 196 | 0.170 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 43 | 0.160 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 336 | 0.160 |
Why?
| | Substantia Nigra | 1 | 2021 | 63 | 0.160 |
Why?
| | Mutation | 3 | 2024 | 4089 | 0.160 |
Why?
| | Cell Aggregation | 1 | 2020 | 19 | 0.160 |
Why?
| | Astrocytes | 1 | 2021 | 222 | 0.150 |
Why?
| | Dimerization | 1 | 2019 | 194 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2019 | 173 | 0.150 |
Why?
| | Genetic Engineering | 1 | 2019 | 93 | 0.140 |
Why?
| | Peptides | 1 | 2025 | 995 | 0.140 |
Why?
| | Lipoylation | 1 | 2018 | 17 | 0.140 |
Why?
| | Integrases | 1 | 2019 | 122 | 0.140 |
Why?
| | Receptors, Retinoic Acid | 2 | 2008 | 42 | 0.140 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 85 | 0.140 |
Why?
| | Recombination, Genetic | 1 | 2019 | 205 | 0.140 |
Why?
| | Botulinum Toxins | 1 | 2019 | 46 | 0.140 |
Why?
| | Membrane Proteins | 3 | 2015 | 1166 | 0.140 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 227 | 0.140 |
Why?
| | A Kinase Anchor Proteins | 1 | 2018 | 70 | 0.130 |
Why?
| | Gene Knock-In Techniques | 2 | 2019 | 61 | 0.130 |
Why?
| | Intellectual Disability | 1 | 2019 | 175 | 0.130 |
Why?
| | Protein Biosynthesis | 2 | 2008 | 458 | 0.110 |
Why?
| | Humans | 15 | 2026 | 144759 | 0.110 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 178 | 0.110 |
Why?
| | Endocannabinoids | 1 | 2015 | 57 | 0.110 |
Why?
| | Capillaries | 3 | 2005 | 124 | 0.110 |
Why?
| | Models, Biological | 2 | 2015 | 1821 | 0.100 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 442 | 0.100 |
Why?
| | Neural Pathways | 1 | 2015 | 311 | 0.100 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 358 | 0.100 |
Why?
| | Neovascularization, Physiologic | 2 | 2005 | 194 | 0.090 |
Why?
| | Retinoic Acid Receptor alpha | 2 | 2008 | 16 | 0.090 |
Why?
| | Carrier Proteins | 2 | 2023 | 737 | 0.090 |
Why?
| | Cryptochromes | 2 | 2019 | 25 | 0.070 |
Why?
| | Dendritic Cells | 1 | 2012 | 499 | 0.070 |
Why?
| | Transfection | 2 | 2008 | 940 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2008 | 154 | 0.070 |
Why?
| | Arabidopsis Proteins | 2 | 2019 | 76 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2527 | 0.070 |
Why?
| | Receptor, Notch1 | 2 | 2005 | 64 | 0.070 |
Why?
| | Patch-Clamp Techniques | 1 | 2008 | 289 | 0.070 |
Why?
| | Dendrites | 1 | 2008 | 106 | 0.070 |
Why?
| | Receptors, Notch | 2 | 2005 | 92 | 0.060 |
Why?
| | Electrophysiology | 1 | 2007 | 218 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2007 | 415 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2007 | 327 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2008 | 635 | 0.060 |
Why?
| | Light | 2 | 2019 | 411 | 0.060 |
Why?
| | Fluorescent Dyes | 2 | 2024 | 329 | 0.060 |
Why?
| | Mental Disorders | 1 | 2015 | 1168 | 0.060 |
Why?
| | Up-Regulation | 1 | 2008 | 851 | 0.060 |
Why?
| | Pinocytosis | 1 | 2025 | 6 | 0.060 |
Why?
| | Neurotransmitter Agents | 2 | 2015 | 82 | 0.060 |
Why?
| | KCNQ3 Potassium Channel | 1 | 2024 | 3 | 0.050 |
Why?
| | KCNQ Potassium Channels | 1 | 2024 | 4 | 0.050 |
Why?
| | Homeostasis | 1 | 2008 | 640 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1716 | 0.050 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2024 | 58 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 459 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 557 | 0.050 |
Why?
| | Receptors, Neurotransmitter | 1 | 2023 | 20 | 0.050 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 67 | 0.050 |
Why?
| | Angiopoietin-1 | 1 | 2003 | 12 | 0.050 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2003 | 26 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 85 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2025 | 252 | 0.050 |
Why?
| | Fibrin | 1 | 2003 | 91 | 0.050 |
Why?
| | Epitopes | 1 | 2024 | 485 | 0.050 |
Why?
| | Memory | 1 | 2025 | 295 | 0.050 |
Why?
| | Fibroblasts | 2 | 2003 | 1034 | 0.040 |
Why?
| | Neostriatum | 1 | 2021 | 37 | 0.040 |
Why?
| | Acetylcholine | 1 | 2021 | 204 | 0.040 |
Why?
| | Umbilical Veins | 3 | 2005 | 59 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1370 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 54 | 0.040 |
Why?
| | Brain Injuries | 1 | 2025 | 507 | 0.040 |
Why?
| | Vesicle-Associated Membrane Protein 2 | 1 | 2019 | 14 | 0.040 |
Why?
| | RNA Splice Sites | 1 | 2019 | 50 | 0.040 |
Why?
| | Learning | 1 | 2023 | 452 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1732 | 0.040 |
Why?
| | SNARE Proteins | 1 | 2019 | 40 | 0.040 |
Why?
| | Dopamine | 1 | 2021 | 283 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2018 | 69 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 125 | 0.030 |
Why?
| | Endosomes | 1 | 2018 | 140 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1519 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2003 | 965 | 0.030 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 60 | 0.030 |
Why?
| | Exocytosis | 1 | 2016 | 84 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2015 | 10 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Glycerides | 1 | 2015 | 17 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2015 | 73 | 0.030 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 26 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1486 | 0.030 |
Why?
| | Gene Targeting | 1 | 2015 | 82 | 0.030 |
Why?
| | Arachidonic Acids | 1 | 2015 | 43 | 0.030 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 15 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2019 | 337 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 116 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2016 | 455 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 315 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 397 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 318 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 375 | 0.020 |
Why?
| | Cell Membrane | 1 | 2015 | 706 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2155 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2930 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 476 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1782 | 0.020 |
Why?
| | Cytoplasmic Granules | 1 | 2008 | 74 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 2050 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3162 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2005 | 27 | 0.010 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2005 | 32 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 57 | 0.010 |
Why?
| | Endopeptidases | 1 | 2005 | 82 | 0.010 |
Why?
| | Carbamates | 1 | 2005 | 52 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2005 | 116 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 2005 | 171 | 0.010 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2005 | 77 | 0.010 |
Why?
| | Placenta Growth Factor | 1 | 2003 | 26 | 0.010 |
Why?
| | Receptor, Notch4 | 1 | 2003 | 3 | 0.010 |
Why?
| | Pregnancy Proteins | 1 | 2003 | 35 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2003 | 71 | 0.010 |
Why?
| | Blood Vessels | 1 | 2005 | 171 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 128 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 138 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 766 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 381 | 0.010 |
Why?
| | Flavonoids | 1 | 2003 | 87 | 0.010 |
Why?
| | Gels | 1 | 2003 | 84 | 0.010 |
Why?
| | Microspheres | 1 | 2003 | 142 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 175 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 983 | 0.010 |
Why?
| | Adenoviridae | 1 | 2003 | 199 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 185 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 292 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 405 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2003 | 212 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 377 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 824 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 623 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 2027 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 965 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 869 | 0.010 |
Why?
| | Skin | 1 | 2003 | 755 | 0.010 |
Why?
| | Cell Line | 1 | 2003 | 2882 | 0.010 |
Why?
| | Transcription Factors | 1 | 2003 | 1741 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2003 | 6429 | 0.010 |
Why?
|
|
Aoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|